Download PDF
Semin Respir Crit Care Med 2008; 29(1): 083-089
DOI: 10.1055/s-2008-1047566
© Thieme Medical Publishers

Venous Thromboembolism Prophylaxis for the General Surgical Patient: Where Do We Stand?

Gloria A. Petralia1 , 2 , Ajay K. Kakkar1 , 2
  • 1Centre for Surgical Sciences, Barts and The London Queen Mary's School of Medicine and Dentistry, London, United Kingdom
  • 2Thrombosis Research Institute, London, United Kingdom
Further Information

Publication History

Publication Date:
26 March 2008 (online)

    Permissions and Reprints

ABSTRACT

Venous thromboembolism (VTE) is a frequent complication in surgical patients, with the potential for long-term disability or fatal outcome. The rationale behind routine use of thromboprophylaxis can be summarized in three points: (1) VTE is frequent in certain surgical populations, (2) VTE may be fatal, (3) thromboprophylaxis is highly effective and safe. In addition to these clinical benefits it has the potential for lowering overall treatment costs by preventing diagnostic procedures and delayed discharge or readmission due to thromboembolism. Surgical patients tend to have more than one risk factor for VTE, and in view of the fact that the effect of that risk is cumulative, it is important to stratify the risk to tailor an adequate prophylaxis strategy. There is consensus that heparins are both effective and safe in preventing VTE in surgical patients. Evidence-based local strategies should be available locally to clinicians and adhered to in order to maximize outcomes. Guidelines are intended to assist surgeons in making decisions in regard to DVT prophylaxis when performing surgical procedures.

KEYWORDS

Venous thrombosis - prevention - pulmonary embolism - surgery - critical care - heparin - low molecular weight heparin - intermittent pneumatic compression devices - thromboembolism clothing - compression stockings

REFERENCES

  • 1 Kakkar V V, Corrigan T, Spindler J et al.. Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery: a double-blind, randomised trial.  Lancet. 1972;  2 101-106
    PubMedGoogle Scholar
  • 2 Caprini J A, Arcelus J I, Hoffman K et al.. Prevention of venous thromboembolism in North America: results of a survey among general surgeons.  J Vasc Surg. 1994;  20 751-758
    PubMedGoogle Scholar
  • 3 Anderson Jr F A, Wheeler H B, Goldberg R J et al.. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.  Arch Intern Med. 1991;  151 933-938
    CrossrefPubMedGoogle Scholar
  • 4 The National Collaborating Centre for Acute Care .Surgical Risk in: Venous Thromboembolism. Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. National Collaborating Centre for Acute Care at The Royal College of Surgeons of England 2007: 42-52
    Google Scholar
  • 5 Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988.  Br J Surg. 1991;  78 849-852
    CrossrefPubMedGoogle Scholar
  • 6 Sandler D A, Martin J F. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis?.  J R Soc Med. 1989;  82 203-205
    CrossrefPubMedGoogle Scholar
  • 7 White R H, Zhou H, Romano P S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.  Thromb Haemost. 2003;  90 446-455
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Kakkar V V, Howe C T, Flanc C, Clarke M B. Natural history of postoperative deep-vein thrombosis.  Lancet. 1969;  2 230-232
    Google Scholar
  • 9 Kearon C. Natural history of venous thromboembolism.  Circulation. 2003;  107(23, Suppl 1) I22-I30
    PubMedGoogle Scholar
  • 10 Agnelli G, Cosmi B, Radicchia S et al.. Features of thrombi and diagnostic accuracy of impedance plethysmography in symptomatic and asymptomatic deep vein thrombosis.  Thromb Haemost. 1993;  70 266-269
    PubMedGoogle Scholar
  • 11 Stein P D, Henry J W. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy.  Chest. 1995;  108 978-981
    CrossrefPubMedGoogle Scholar
  • 12 Geerts W H, Pineo G F, Heit J A et al.. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126(Suppl 3) 338S-400S
    CrossrefPubMedGoogle Scholar
  • 13 Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery.  N Engl J Med. 1988;  318 1162-1173
    CrossrefPubMedGoogle Scholar
  • 14 Shojania K G, Duncan B W, McDonald K M, Wachter R M, Markowitz A J. Making health care safer: a critical analysis of patient safety practices.  Evid Rep Technol Assess (Summ). 2001;  (43) i-x, 1-668
    PubMedGoogle Scholar
  • 15 Kakkar V V, Cohen A T, Edmonson R A et al.. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group.  Lancet. 1993;  341 259-265
    CrossrefPubMedGoogle Scholar
  • 16 Bick R L. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism.  Drugs. 2000;  60 575-595
    PubMedGoogle Scholar
  • 17 Rosendaal F R. Venous thrombosis: a multicausal disease.  Lancet. 1999;  353 1167-1173
    CrossrefPubMedGoogle Scholar
  • 18 Kakkar V V, Howe C T, Nicolaides A N, Renney J T, Clarke M B. Deep vein thrombosis of the leg: is there a “high risk” group?.  Am J Surg. 1970;  120 527-530
    Google Scholar
  • 19 Rahr H B, Sorensen J V. Venous thromboembolism and cancer.  Blood Coagul Fibrinolysis. 1992;  3 451-460
    PubMedGoogle Scholar
  • 20 Petralia G, McManus A, Kakkar A. Thromboprophylaxis in cancer surgery. In: Khorana A, Francis CW Cancer-Associated Thrombosis: New Findings in Translational Science, Prevention and Treatment. 1st ed. New York; Informa Healthcare 2007: 193-202
    Google Scholar
  • 21 Petralia P, Kakkar A K. Antithrombotic therapy with low molecular weight heparin in cancer patients [review].  Eur J Med Res. 2004;  9 119-124
    PubMedGoogle Scholar
  • 22 Walsh J J, Bonnar J, Wright F W. A study of pulmonary embolism and deep vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning.  J Obstet Gynaecol Br Commonw. 1974;  81 311-316
    PubMedGoogle Scholar
  • 23 Hills N H, Pflug J J, Jeyasingh K, Boardman L, Calnan J S. Prevention of deep vein thrombosis by intermittent pneumatic compression of calf.  BMJ. 1972;  1 131-135
    PubMedGoogle Scholar
  • 24 Rosenberg I L, Evans M, Pollock A V. Prophylaxis of postoperative deep vein thrombosis [letter].  Br Med J. 1975;  3 228
    PubMedGoogle Scholar
  • 25 Rem J, Duckert F, Fridrich R, Gruber U F. Subcutaneous small heparin doses for the prevention of thrombosis in general surgery and urology.  Schweiz Med Wochenschr. 1975;  105 827-835
    PubMedGoogle Scholar
  • 26 Gallus A S, Hirsh J, O'Brien S E, McBride J A, Tuttle R J, Gent M. Prevention of venous thrombosis with small, subcutaneous doses of heparin.  JAMA. 1976;  235 1980-1982
    CrossrefPubMedGoogle Scholar
  • 27 Allan A, Williams J T, Bolton J P, Le Quesne L P. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis.  Br J Surg. 1983;  70 172-174
    CrossrefPubMedGoogle Scholar
  • 28 The Multicenter Trial Committee . Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis: a multicenter trial.  JAMA. 1984;  251 2960-2966
    CrossrefPubMedGoogle Scholar
  • 29 Kakkar V V, Murray W J. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: a cooperative study.  Br J Surg. 1985;  72 786-791
    PubMedGoogle Scholar
  • 30 Sue-Ling H M, Johnston D, McMahon M J, Philips P R, Davies J A. Preoperative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery.  Lancet. 1986;  1 1173-1176
    PubMedGoogle Scholar
  • 31 Tsai A W, Cushman M, Rosamond W D, Heckbert S R, Polak J F, Folsom A R. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology.  Arch Intern Med. 2002;  162 1182-1189
    CrossrefPubMedGoogle Scholar
  • 32 Hendolin H, Mattila M A, Poikolainen E. The effect of lumbar epidural analgesia on the development of deep vein thrombosis of the legs after open prostatectomy.  Acta Chir Scand. 1981;  147 425-429
    PubMedGoogle Scholar
  • 33 Jaffer A K, Barsoum W K, Krebs V, Hurbanek J G, Morra N, Brotman D J. Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.  Mayo Clin Proc. 2005;  80 732-738
    Google Scholar
  • 34 Riber C, Alstrup N, Nymann T, Bogstad J W, Wille-Jorgensen P, Tonnesen H. Postoperative thromboembolism after day-case herniorrhaphy.  Br J Surg. 1996;  83 420-421
    PubMedGoogle Scholar
  • 35 Samama C M, Albaladejo P, Benhamou D et al.. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines.  Eur J Anaesthesiol. 2006;  23 95-116
    CrossrefPubMedGoogle Scholar
  • 36 Lindberg F, Bergqvist D, Rasmussen I. Incidence of thromboembolic complications after laparoscopic cholecystectomy: review of the literature.  Surg Laparosc Endosc. 1997;  7 324-331
    CrossrefPubMedGoogle Scholar
  • 37 Bergqvist D, Matzsch T, Jendteg S, Lindgren B, Persson U. The cost-effectiveness of prevention of post-operative thromboembolism.  Acta Chir Scand Suppl. 1990;  556 36-41
    PubMedGoogle Scholar
  • 38 Lind T. Changing surgical principles for gastro-oesophageal reflux disease: is laparoscopic fundoplication justified in the light of surgical complications?.  Eur J Surg Suppl. 2000;  585 31-33
    PubMedGoogle Scholar
  • 39 Mall J W, Schwenk W, Rodiger O, Zippel K, Pollmann C, Muller J M. Blinded prospective study of the incidence of deep venous thrombosis following conventional or laparoscopic colorectal resection.  Br J Surg. 2001;  88 99-100
    CrossrefPubMedGoogle Scholar
  • 40 Hamad G G, Choban P S. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.  Obes Surg. 2005;  15 1368-1374
    CrossrefPubMedGoogle Scholar
  • 41 Gugliotti D V. What is the optimal venous thromboembolism prophylaxis for patients undergoing bariatric surgery? IMPACT consults. Proceedings of the 2nd Annual Cleveland Clinic Perioperative Medicine Summit.  Cleve Clin J Med. 2006;  73(Electronic Suppl 1) S17-S18
    PubMedGoogle Scholar
  • 42 Westling A, Bergqvist D, Bostrom A, Karacagil S, Gustavsson S. Incidence of deep venous thrombosis in patients undergoing obesity surgery.  World J Surg. 2002;  26 470-473
    CrossrefPubMedGoogle Scholar
  • 43 Prystowsky J B, Morasch M D, Eskandari M K, Hungness E S, Nagle A P. Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patients.  Surgery. 2005;  138 759-763 discussion 763-765
    CrossrefPubMedGoogle Scholar
  • 44 Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge: an underestimated risk.  Arch Surg. 1992;  127 310-313
    CrossrefPubMedGoogle Scholar
  • 45 Heit J A, O'Fallon W M, Petterson T M et al.. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study.  Arch Intern Med. 2002;  162 1245-1248
    CrossrefPubMedGoogle Scholar
  • 46 Bergqvist D, Agnelli G, Cohen A T et al.. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.  , [see comment] N Engl J Med. 2002;  346 975-980
    CrossrefPubMedGoogle Scholar
  • 47 Abrams C S, Ellison N, Budzynski A Z, Shattil S J. Direct detection of activated platelets and platelet-derived microparticles in humans.  Blood. 1990;  75 128-138
    PubMedGoogle Scholar
  • 48 Agu O, Hamilton G, Baker D. Graduated compression stockings in the prevention of venous thromboembolism.  Br J Surg. 1999;  86 992-1004
    CrossrefPubMedGoogle Scholar
  • 49 Haas S B, Tribus C B, Insall J N, Becker M W, Windsor R E. The significance of calf thrombi after total knee arthroplasty.  J Bone Joint Surg Br. 1992;  74 799-802
    PubMedGoogle Scholar
  • 50 Kalodiki E, Domjan J, Nicolaides A N et al.. V/Q defects and deep venous thrombosis following total hip replacement.  Clin Radiol. 1995;  50 400-403
    PubMedGoogle Scholar
  • 51 Hull R D, Pineo G F, Stein P D et al.. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.  Ann Intern Med. 2001;  135 858-869
    CrossrefPubMedGoogle Scholar
  • 52 Eikelboom J W, Quinlan D J, Douketis J D. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials.  Lancet. 2001;  358 9-15
    CrossrefPubMedGoogle Scholar
  • 53 Mismetti P, Laporte S, Darmon J Y, Buchmuller A, Decousus H. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery.  , [see comment] Br J Surg. 2001;  88 913-930
    CrossrefPubMedGoogle Scholar
  • 54 Douketis J D, Eikelboom J W, Quinlan D J, Willan A R, Crowther M A. Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes.  Arch Intern Med. 2002;  162 1465-1471
    CrossrefPubMedGoogle Scholar
  • 55 Pulmonary Embolism Prevention (PEP) Trial Collaborative Group . Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial.  Lancet. 2000;  355(9212) 1295-1302
    CrossrefPubMedGoogle Scholar
  • 56 Zurawska U, Parasuraman S, Goldhaber S Z. Prevention of pulmonary embolism in general surgery patients.  Circulation. 2007;  115 e302-e307
    CrossrefPubMedGoogle Scholar
  • 57 Clagett G P, Reisch J S. Prevention of venous thromboembolism in general surgical patients: results of meta-analysis.  Ann Surg. 1988;  208 227-240
    CrossrefPubMedGoogle Scholar
  • 58 Bergqvist D, Burmark U S, Flordal P A et al.. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients.  , [see comment] Br J Surg. 1995;  82 496-501
    CrossrefPubMedGoogle Scholar
  • 59 Warkentin T E, Levine M N, Hirsh J et al.. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin.  , [see comment] N Engl J Med. 1995;  332 1330-1335
    CrossrefPubMedGoogle Scholar
  • 60 Agnelli G, Bergqvist D, Gallus A, Gent M. A randomised double-blind study to compare the efficacy and safety of fondaparinux with deltaparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus study.  J Thromb Haemost. 2003;  1(Suppl 1) OC006
    PubMedGoogle Scholar
  • 61 Agnelli G, Bergqvist D, Cohen A T, Gallus A S, Gent M. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.  Br J Surg. 2005;  92 1212-1220
    CrossrefPubMedGoogle Scholar
  • 62 Richardson W, Apelgren K, Earle D, Fanelli R. Guidelines for deep venous thrombosis prophylaxis during laparoscopic surgery.  Surg Endosc. 2007;  21 2331-2334
    CrossrefPubMedGoogle Scholar

Gloria A PetraliaM.D. 

Centre for Surgical Sciences, Barts and the London Queen Mary's School of Medicine and Dentistry, Old Anatomy Bldg.

Charterhouse Sq., London EC1M 6BQ, UK

Email: petralia@tri-london.ac.uk